Found: 37
Select item for more details and to access through your institution.
Homologous Recombination Deficiency (HRD) as a Potential Pan-Cancer Biomarker for PARP Inhibition.
- Published in:
- Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 3, p. 241, doi. 10.36401/JIPO-24-X2
- By:
- Publication type:
- Article
Evolving and Improving the Sustainability of Molecular Tumor Boards: The Value and Challenges.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2888, doi. 10.3390/cancers16162888
- By:
- Publication type:
- Article
Minimizing acquisition-related radiomics variability by image resampling and batch effect correction to allow for large-scale data analysis.
- Published in:
- European Radiology, 2021, v. 31, n. 3, p. 1460, doi. 10.1007/s00330-020-07174-0
- By:
- Publication type:
- Article
Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario.
- Published in:
- Journal of Market Access & Health Policy, 2022, v. 10, n. 1, p. 1, doi. 10.1080/20016689.2022.2077905
- By:
- Publication type:
- Article
Combined Modality Therapy of Stage IIIC Breast Cancer.
- Published in:
- Breast Journal, 2011, v. 17, n. 3, p. 331, doi. 10.1111/j.1524-4741.2011.01086.x
- By:
- Publication type:
- Article
Development of molecular biomarkers in individualized treatment of colorectal cancer.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Public and patient involvement: a survey on knowledge, experience and opinions among researchers within a precision oncology European project.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11262-x
- By:
- Publication type:
- Article
Intrinsic cancer subtypes-next steps into personalized medicine.
- Published in:
- Cellular Oncology (2211-3428), 2015, v. 38, n. 1, p. 3, doi. 10.1007/s13402-014-0203-7
- By:
- Publication type:
- Article
Complete Response to Immunotherapy in a Patient with MUTYH-Associated Polyposis and Gastric Cancer: A Case Report.
- Published in:
- Case Reports in Oncology, 2023, v. 16, n. 1, p. 510, doi. 10.1159/000530965
- By:
- Publication type:
- Article
A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking?
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00534-9
- By:
- Publication type:
- Article
The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models.
- Published in:
- Genome Medicine, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13073-024-01370-z
- By:
- Publication type:
- Article
PI3K activation promotes resistance to eribulin in HER2-negative breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
New clinical trial designs in the era of precision medicine.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 3, p. 549, doi. 10.1002/1878-0261.12465
- By:
- Publication type:
- Article
Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 9, p. 1263, doi. 10.1002/1878-0261.12099
- By:
- Publication type:
- Article
Optimal design of trials to demonstrate the utility of genomically-guided therapy: Putting Precision Cancer Medicine to the test.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 5, p. 940, doi. 10.1016/j.molonc.2014.06.014
- By:
- Publication type:
- Article
Standardized decision support in next generation sequencing reports of somatic cancer variants.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 5, p. 859, doi. 10.1016/j.molonc.2014.03.021
- By:
- Publication type:
- Article
Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer
- Published in:
- Molecular Oncology, 2012, v. 6, n. 1, p. 15, doi. 10.1016/j.molonc.2011.11.009
- By:
- Publication type:
- Article
Precision cancer medicine: Concepts, current practice, and future developments.
- Published in:
- Journal of Internal Medicine, 2023, v. 294, n. 4, p. 455, doi. 10.1111/joim.13709
- By:
- Publication type:
- Article
PCIG: a web-based application to explore immune–genomics interactions across cancer types.
- Published in:
- Bioinformatics, 2022, v. 38, n. 8, p. 2374, doi. 10.1093/bioinformatics/btac111
- By:
- Publication type:
- Article
Toxicity as a Biomarker of Efficacy of Molecular Targeted Therapies: Focus on EGFR and VEGF Inhibiting Anticancer Drugs.
- Published in:
- Oncologist, 2011, v. 16, n. 12, p. 1729, doi. 10.1634/theoncologist.2011-0163
- By:
- Publication type:
- Article
Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-49867-7
- By:
- Publication type:
- Article
Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920936089
- By:
- Publication type:
- Article
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00282-0
- By:
- Publication type:
- Article
Benefit-risk assessment of bevacizumab in the treatment of breast cancer.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations.
- Published in:
- Genome Medicine, 2018, v. 10, p. 1, doi. 10.1186/s13073-018-0531-8
- By:
- Publication type:
- Article
Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3611, doi. 10.3390/cancers15143611
- By:
- Publication type:
- Article
Evolution of Angiogenic Factors in Pregnant Patients with Breast Cancer Treated with Chemotherapy.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 923, doi. 10.3390/cancers13040923
- By:
- Publication type:
- Article
The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The consensus molecular subtypes of colorectal cancer.
- Published in:
- Nature Medicine, 2015, v. 21, n. 11, p. 1350, doi. 10.1038/nm.3967
- By:
- Publication type:
- Article
Genomic Testing in Colorectal Cancer: How Much Is Enough?
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Genomic Testing in Colorectal Cancer: How Much Is Enough?
- Published in:
- Oncology (08909091), 2015, v. 29, n. 3, p. 186
- By:
- Publication type:
- Article
A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 1065, doi. 10.1007/s00280-015-2728-5
- By:
- Publication type:
- Article
Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-00831-4
- By:
- Publication type:
- Article
Combination of novel molecular targeted agent plus R-CHOP-based regimen versus R-CHOP alone in previously untreated diffuse large B-cell lymphoma (DLBCL) patients: a systematic review and meta-analysis.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 12, p. 2969, doi. 10.1007/s00277-021-04623-8
- By:
- Publication type:
- Article
Electric hand warmer versus observation to avoid discomfort during scalp cooling for chemotherapy-induced alopecia prevention: a randomized study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-46840-3
- By:
- Publication type:
- Article
The somatic mutation profile of estrogen receptor-positive HER2-negative metastatic breast cancer in Brazilian patients.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1372947
- By:
- Publication type:
- Article
First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid Tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article